Ziopharm Oncology
ZIOP
#8631
Rank
$0.18 B
Marketcap
$0.87
Share price
-0.88%
Change (1 day)
-74.86%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -$89.28 Million USD

According to Ziopharm Oncology's latest financial reports the company's current earnings are $3.73 Million USD. In 2020 the company made an earning of -$80.37 Million USD a decrease over its 2019 earnings that were of -$57.86 Million USD.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-$89.28 Million11.09%
2020-$80.37 Million38.89%
2019-$57.86 Million7.33%
2018-$53.91 Million0.77%
2017-$53.5 Million-67.64%
2016-$0.17 Billion37.64%
2015-$0.13 Billion176.1%
2014-$43.5 Million-24.63%
2013-$57.72 Million-43.51%
2012-$0.11 Billion43.09%
2011-$71.4 Million190.88%
2010-$24.55 Million102.46%
2009-$12.13 Million-52.68%
2008-$25.62 Million-10.33%
2007-$28.58 Million15.35%
2006-$24.77 Million355.36%
2005-$5.44 Million13788.35%
2004-$0.04 Million9.27%
2003-$0.04 Million-10.26%
2002-$0.04 Million-59.35%
2001-$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
$8.97 B-10,154.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-$0.51 Billion 465.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.32 B-10,548.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-$2.76 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA